Latest Regulatory Approval News

The Fair Competition Commission of Tanzania has approved Shenghe Resources’ acquisition of Peak Rare Earths, clearing a major regulatory hurdle for the deal. The scheme now awaits Australian court approval and independent expert endorsement.

Peak Rare Earths has postponed its critical court hearing for Shenghe Resources' acquisition scheme due to a delay in Tanzanian regulatory approval, pushing the decision to 19 September 2025.

Argent Minerals has reported outstanding high-grade silver and polymetallic mineralisation from diamond drillhole AKDD208 at its Kempfield project, revealing extensive zones that could significantly boost the resource base.

Andromeda Metals' latest Scoping Study reveals a compelling economic case for its innovative High Purity Alumina (HPA) production technology, highlighting strong returns and a significant carbon emissions advantage. The project aims to meet soaring global demand with a 10,000 tonne per annum facility in South Australia.

Tempest Minerals has secured regulatory approval to begin Phase I drilling at its Halo prospect within the Yalgoo Project, targeting iron, copper, and gold. A heritage survey with the Badimia People is currently in progress, marking a key step toward unlocking the site's potential.

Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.

Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.

Argent Minerals has reported outstanding high-grade silver and polymetallic mineralisation from diamond drillhole AKDD208 at its Kempfield Project, significantly enhancing the deposit’s resource potential.

OncoSil Medical’s PANCOSIL Phase 1-2 study reveals promising safety and feasibility for a novel CT-guided pancreatic cancer therapy, with survival outcomes exceeding historical benchmarks.

Dundee Precious Metals Inc. has completed its acquisition of Adriatic Metals Plc through a UK scheme of arrangement, gaining control of the Vareš Silver Operation. The deal, valued at approximately USD 1.3 billion, offers Adriatic shareholders a mix of cash and new DPM shares, underpinned by a detailed technical valuation.

Battery Age Minerals Limited has launched an offer of up to 29 million quoted options following a $3 million placement, aiming to support exploration projects in Austria and Argentina while managing shareholder dilution.

Memphasys has upgraded its contract with ITL to A$390,000 and expanded its territory to include Turkey, marking its first contracted revenues in the EU ahead of expected CE Mark approval.